{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:49:54Z","timestamp":1773888594797,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.biopha.2016.10.045","type":"journal-article","created":{"date-parts":[[2016,10,29]],"date-time":"2016-10-29T16:01:14Z","timestamp":1477756874000},"page":"1406-1418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Expression of adenosine receptors and vegf during angiogenesis and its inhibition by pentoxifylline\u2014A study using zebrafish model"],"prefix":"10.1016","volume":"84","author":[{"given":"Jhansi Rani","family":"Nathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh","family":"Lakshmanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicia Mary","family":"Michael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakash","family":"Seppan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malathi","family":"Ragunathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2016.10.045_bib0005","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/med.20059","article-title":"Anti-angiogenic drugs: from bench to clinical trials","volume":"26","author":"Quesada","year":"2006","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biopha.2016.10.045_bib0010","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","article-title":"Angiogenesis in life, disease and medicine","volume":"438","author":"Carmeliet","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2016.10.045_bib0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jnci\/82.1.4","article-title":"What is the evidence that tumors are angiogenesis dependent?","volume":"82","author":"Folkman","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.biopha.2016.10.045_bib0020","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/cncr.20299","article-title":"Vascular-targeting therapies for treatment of malignant disease","volume":"100","author":"Siemann","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2016.10.045_bib0025","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1517\/14728222.11.11.1443","article-title":"Tumor targeting by microtubule-depolymerizing vascular disrupting agents","volume":"11","author":"Kanthou","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2016.10.045_bib0030","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1472-8206.2003.00156.x","article-title":"Ginkgo biloba extracts and cancer: a research area in its infancy","volume":"17","author":"DeFeudis","year":"2003","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2016.10.045_bib0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cncr.11873","article-title":"Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression","volume":"100","author":"B\u00fcchler","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2016.10.045_bib0040","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","article-title":"Angiogenesis as a therapeutic target","volume":"438","author":"Ferrara","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2016.10.045_bib0045","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.biopha.2016.10.045_bib0050","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrc1369","article-title":"The anti-angiogenic basis of metronomic chemotherapy","volume":"4","author":"Kerbel","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2016.10.045_bib0055","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1073\/pnas.172398299","article-title":"VEGF-Trap: a VEGF blocker with potent antitumor effects","volume":"99","author":"Holash","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2016.10.045_bib0060","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1126\/science.1095920","article-title":"Protein kinase inhibitors: insights into drug design from structure","volume":"303","author":"Noble","year":"2004","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2016.10.045_bib0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ophtha.2005.10.012","article-title":"Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals","volume":"113","author":"Adamis","year":"2006","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.biopha.2016.10.045_bib0070","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0002-9440(10)64773-6","article-title":"Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization","volume":"156","author":"Ozaki","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.biopha.2016.10.045_bib0075","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm0603-677","article-title":"Regulation of angiogenesis by hypoxia: role of the HIF system","volume":"9","author":"Pugh","year":"2003","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.biopha.2016.10.045_bib0080","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","article-title":"International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2016.10.045_bib0085","first-page":"151","article-title":"Characterization of the adenosine receptors in the airways","volume":"329","author":"Pauwels","year":"1995","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2016.10.045_bib0090","first-page":"598","article-title":"Pentoxifylline inhibits hypoxia-induced upregulation of tumor cell tissue factor and vascular endothelial growth factor","volume":"80","author":"Amirkhosravi","year":"1998","journal-title":"Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.biopha.2016.10.045_bib0095","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s004320100262","article-title":"Inhibition of endothelial cell proliferation and tumor-induced angiogenesis by pentoxifylline","volume":"127","author":"Gude","year":"2001","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2016.10.045_bib0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt1169","article-title":"Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression","volume":"24","author":"Lam","year":"2006","journal-title":"Nat. Biotechnol."},{"issue":"8","key":"10.1016\/j.biopha.2016.10.045_bib0105","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nbt852","article-title":"Chemical discovery and global gene expression analysis in zebrafish","volume":"21","author":"Pichler","year":"2003","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.biopha.2016.10.045_bib0110","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/dbio.2000.9995","article-title":"The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development","volume":"230","author":"Isogai","year":"2001","journal-title":"Dev. Biol."},{"key":"10.1016\/j.biopha.2016.10.045_bib0115","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2741\/1092","article-title":"Zebrafish: a genetic model for vertebrate organogenesis and human disorders","volume":"8","author":"Ackermann","year":"2003","journal-title":"Front. Biosci."},{"issue":"2","key":"10.1016\/j.biopha.2016.10.045_bib0120","first-page":"218","article-title":"Zebrafish: from disease modeling to drug discovery","volume":"6","author":"Rubinstein","year":"2003","journal-title":"Curr. Opin. Drug Discov. Devel."},{"issue":"16","key":"10.1016\/j.biopha.2016.10.045_bib0125","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.1073\/pnas.162366299","article-title":"Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish","volume":"99","author":"Lee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.biopha.2016.10.045_bib0130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/aja.1002030302","article-title":"Stages of embryonic development of the zebrafish","volume":"203","author":"Kimmel","year":"1995","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.biopha.2016.10.045_bib0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/jez.1402260311","article-title":"Erythropoiesis in the developing rainbow trout, Salmo gairdneri irideus: histochemical and immunochemical detection of erythropoietic organs","volume":"226","author":"Iuchi","year":"1983","journal-title":"J. Exp. Zool."},{"issue":"1","key":"10.1016\/j.biopha.2016.10.045_bib0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nprot.2010.165","article-title":"Embedding serial sectioning and staining of zebrafish embryos using JB-4 resin","volume":"6","author":"Sullivan-Brown","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2016.10.045_bib0145","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bionut.2012.03.001","article-title":"Anti-angiogenic effects of theophylline on developing zebrafish (Danio rerio) embryos","volume":"2","author":"Bakkiyanathan","year":"2012","journal-title":"Biomed. Preventive Nutr."},{"key":"10.1016\/j.biopha.2016.10.045_bib0150","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/jat.2787","article-title":"Exposure time to caffeine affects heartbeat and cell damage-related gene expression of zebrafish Danio rerio embryos at early developmental stages","volume":"33","author":"Abdelkader","year":"2013","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.biopha.2016.10.045_bib0155","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1242\/dev.123.1.293","article-title":"Mutations affecting the cardiovascular system and other internal organs in zebrafish","volume":"123","author":"Chen","year":"1996","journal-title":"Development"},{"key":"10.1016\/j.biopha.2016.10.045_bib0160","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1242\/dev.123.1.285","article-title":"Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo","volume":"123","author":"Stainier","year":"1996","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.biopha.2016.10.045_bib0165","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jcb.22405","article-title":"Resveratrol derivative, trans-3,5,4'-trimethoxystilbene, exerts antiangiogenic and vascular-disrupting effects in zebrafish through the downregulation of VEGFR2 and cell-cycle modulation","volume":"109","author":"Alex","year":"2010","journal-title":"J. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.biopha.2016.10.045_bib0170","first-page":"2048","article-title":"Anti-angiogenic activity of myricetin through VEGF-A down regulation in Zebrafish (danio rerio) invivo","volume":"4","author":"Thamilarashi","year":"2013","journal-title":"Int. J. Sci. Eng. Res."},{"key":"10.1016\/j.biopha.2016.10.045_bib0175","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.RES.85.8.699","article-title":"Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells","volume":"85","author":"Grant","year":"1999","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.biopha.2016.10.045_bib0180","doi-asserted-by":"crossref","first-page":"L733","DOI":"10.1152\/ajplung.2000.279.4.L733","article-title":"Adenosine induces endothelial apoptosis by activating protein tyrosine phosphatase: a possible role of p38alpha","volume":"279","author":"Harrington","year":"2000","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.biopha.2016.10.045_bib0185","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/01.RES.0000061572.10929.2D","article-title":"Mast Cell\u2013Mediated stimulation of angiogenesis cooperative interaction between A2 B and A3 adenosine receptors","volume":"92","author":"Feoktistov","year":"2003","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.biopha.2016.10.045_bib0190","first-page":"2774","article-title":"Pentoxifylline inhibition of vasculogenesis in the neonatal rat retina","volume":"41","author":"Hasebe","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2016.10.045_bib0195","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1471-213X-7-114","article-title":"Genetic determinants of hyaloid and retinal vasculature in zebrafish","volume":"7","author":"Alvarez","year":"2007","journal-title":"BMC Dev. Biol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216310162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216310162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:31:34Z","timestamp":1773873094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216310162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":39,"alternative-id":["S0753332216310162"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.10.045","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of adenosine receptors and vegf during angiogenesis and its inhibition by pentoxifylline\u2014A study using zebrafish model","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.10.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}